v3.25.2

Share Data and Net Assets (Tables) | 9 Months Ended
--- | ---
Jun. 30, 2025
Stockholders' Equity Note [Abstract] |
Schedule of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the three and nine months ended June 30, 2025 and 2024:
(Share amounts in thousands) |  | Three months ended June 30, 2025 |  | Three months ended June 30, 2024 |  | Nine months ended June 30, 2025 |  | Nine months ended June 30, 2024
Earnings (loss) per common share — basic and diluted: |  |  |  |  |  |  |  |
Net increase (decrease) in net assets resulting from operations |  | $ | 38,352 |  |  | $ | 1,120 |  |  | $ | 9,342 |  |  | $ | 20,992 |
Weighted average common shares outstanding — basic and diluted |  | 88,086 |  |  | 81,830 |  |  | 85,402 |  |  | 79,804 |
Earnings (loss) per common share — basic and diluted |  | $ | 0.44 |  |  | $ | 0.01 |  |  | $ | 0.11 |  |  | $ | 0.26 |
Schedule of Changes in Net Assets | The following table presents the changes in net assets for the three and nine months ended June 30, 2025:
|  | Common Stock |  |  |  |  |  |
(Share amounts in thousands) |  | Shares |  | Par Value |  | Additional paid-in-capital |  | Accumulated Overdistributed Earnings |  | Total Net Assets
Balance as of September 30, 2024 |  | 82,245 |  |  | $ | 822 |  |  | $ | 2,264,449 |  |  | $ | (777,460) |  |  | $ | 1,487,811 |
Net investment income |  | — |  |  | — |  | — |  | 44,302 |  | 44,302
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | (19,614) |  | (19,614)
Net realized gains (losses) |  | — |  | — |  | — |  | (17,310) |  | (17,310)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (139) |  | (139)
Distributions to stockholders |  | — |  | — |  | — |  | (45,235) |  | (45,235)
Issuance of common stock under dividend reinvestment plan |  | 95 |  | 1 |  | 1,454 |  | — |  | 1,455
Repurchase of common stock under dividend reinvestment plan |  | (95) |  | (1) |  | (1,454) |  | — |  | (1,455)
Balance as of December 31, 2024 |  | 82,245 |  |  | $ | 822 |  |  | $ | 2,264,449 |  |  | $ | (815,456) |  |  | $ | 1,449,815 |
Net investment income |  | — |  |  | — |  |  | — |  |  | 39,055 |  |  | 39,055
Net unrealized appreciation (depreciation) |  | — |  |  | — |  |  | — |  |  | (82,023) |  |  | (82,023)
Net realized gains (losses) |  | — |  |  | — |  |  | — |  |  | 6,705 |  |  | 6,705
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  |  | — |  |  | — |  |  | 14 |  |  | 14
Distributions to stockholders |  | — |  |  | — |  |  | — |  |  | (41,400) |  |  | (41,400)
Issuance of common stock under dividend reinvestment plan |  | 276 |  |  | 3 |  |  | 4,286 |  |  | — |  |  | 4,289
Repurchase of common stock under dividend reinvestment plan |  | (276) |  |  | (3) |  |  | (4,286) |  |  | — |  |  | (4,289)
Issuance of common stock in private placement |  | 5,672 |  |  | 57 |  |  | 99,943 |  |  | — |  |  | 100,000
Issuance of common stock in connection with the "at the market" offering |  | 169 |  |  | 2 |  |  | 2,945 |  |  | — |  |  | 2,947
Balance as of March 31, 2025 |  | 88,086 |  |  | $ | 881 |  |  | $ | 2,367,337 |  |  | $ | (893,105) |  |  | $ | 1,475,113 |
Net investment income |  | — |  |  | — |  |  | — |  |  | 33,481 |  |  | 33,481
Net unrealized appreciation (depreciation) |  | — |  |  | — |  |  | — |  |  | 18,572 |  |  | 18,572
Net realized gains (losses) |  | — |  |  | — |  |  | — |  |  | (13,432) |  |  | (13,432)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  |  | — |  |  | — |  |  | (269) |  |  | (269)
Distributions to stockholders |  | — |  |  | — |  |  | — |  |  | (36,996) |  |  | (36,996)
Issuance of common stock under dividend reinvestment plan |  | 269 |  |  | 3 |  |  | 3,748 |  |  | — |  |  | 3,751
Repurchase of common stock under dividend reinvestment plan |  | (269) |  |  | (3) |  |  | (3,748) |  |  | — |  |  | (3,751)
Balance as of June 30, 2025 |  | 88,086 |  |  | $ | 881 |  |  | $ | 2,367,337 |  |  | $ | (891,749) |  |  | $ | 1,476,469 |
The following table presents the changes in net assets for the three and nine months ended June 30, 2024:
|  | Common Stock |  |  |  |  |  |
(Share amounts in thousands) |  | Shares |  | Par Value |  | Additional paid-in-capital |  | Accumulated Overdistributed Earnings |  | Total Net Assets
Balance as of September 30, 2023 |  | 77,225 |  |  | $ | 772 |  |  | $ | 2,166,330 |  |  | $ | (651,338) |  |  | $ | 1,515,764 |
Net investment income |  | — |  |  | — |  | — |  | 44,189 |  | 44,189
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | (25,025) |  | (25,025)
Net realized gains (losses) |  | — |  | — |  | — |  | (8,453) |  | (8,453)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (176) |  | (176)
Distributions to stockholders |  | — |  | — |  | — |  | (48,897) |  | (48,897)
Issuance of common stock in connection with the "at the market" offering |  | 1,641 |  | 17 |  | 32,296 |  | — |  | 32,313
Issuance of common stock under dividend reinvestment plan |  | 99 |  | 1 |  | 1,935 |  | — |  | 1,936
Balance as of December 31, 2023 |  | 78,965 |  |  | $ | 790 |  |  | $ | 2,200,561 |  |  | $ | (689,700) |  |  | $ | 1,511,651 |
Net investment income |  | — |  |  | — |  | — |  | 41,367 |  | 41,367
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | (25,252) |  | (25,252)
Net realized gains (losses) |  | — |  | — |  | — |  | (6,603) |  | (6,603)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (175) |  | (175)
Distributions to stockholders |  | — |  | — |  | — |  | (44,715) |  | (44,715)
Issuance of common stock in connection with the "at the market" offering |  | 2,334 |  | 23 |  | 45,950 |  | — |  | 45,973
Issuance of common stock under dividend reinvestment plan |  | 97 |  | 1 |  | 1,852 |  | — |  | 1,853
Balance as of March 31, 2024 |  | 81,396 |  |  | $ | 814 |  |  | $ | 2,248,363 |  |  | $ | (725,078) |  |  | $ | 1,524,099 |
Net investment income |  | — |  |  | — |  | — |  | 44,575 |  | 44,575
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | 26,199 |  | 26,199
Net realized gains (losses) |  | — |  | — |  | — |  | (69,452) |  | (69,452)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (202) |  | (202)
Distributions to stockholders |  | — |  | — |  | — |  | (45,180) |  | (45,180)
Issuance of common stock in connection with the "at the market" offering |  | 749 |  | 7 |  | 14,214 |  | — |  | 14,221
Issuance of common stock under dividend reinvestment plan |  | 100 |  | 1 |  | 1,872 |  | — |  | 1,873
Balance as of June 30, 2024 |  | 82,245 |  |  | $ | 822 |  |  | $ | 2,264,449 |  |  | $ | (769,138) |  |  | $ | 1,496,133 |
Schedule of Distributions | The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the nine months ended June 30, 2025 and 2024:
Distribution |  | Date Declared |  | Record Date |  | Payment Date |  | Amount per Share |  | Cash Distribution |  | DRIP Shares Issued |  | DRIP Shares Value (3) |  |
Quarterly |  | November 7, 2024 |  | December 16, 2024 |  | December 31, 2024 |  | $ | 0.55 |  |  | $ | 43.8 | million |  | 94,970 |  | (1) | $ | 1.5 | million |  |
Quarterly |  | January 27, 2025 |  | March 17, 2025 |  | March 31, 2025 |  | $ | 0.40 |  |  | $ | 31.5 | million |  | 234,752 |  | (1) | $ | 3.7 | million |  |
Supplemental |  | January 27, 2025 |  | March 17, 2025 |  | March 31, 2025 |  | $ | 0.07 |  |  | $ | 5.6 | million |  | 41,082 |  | (1) | $ | 0.6 | million |  |
Quarterly |  | April 28, 2025 |  | June 16, 2025 |  | June 30, 2025 |  | $ | 0.40 |  |  | $ | 31.6 | million |  | 256,343 |  | (1) | $ | 3.6 | million |  |
Supplemental |  | April 28, 2025 |  | June 16, 2025 |  | June 30, 2025 |  | $ | 0.02 |  |  | $ | 1.6 | million |  | 12,817 |  | (1) | $ | 0.2 | million |  |
Total for the nine months ended June 30, 2025 |  | $ | 1.44 |  |  | $ | 114.1 | million |  | 639,964 |  |  | $ | 9.5 | million |  |
Distribution |  | Date Declared |  | Record Date |  | Payment Date |  | Amount per Share |  | Cash Distribution |  | DRIP Shares Issued |  | DRIP Shares Value |  |
Quarterly |  | November 8, 2023 |  | December 15, 2023 |  | December 29, 2023 |  | $ | 0.55 |  |  | $ | 41.7 | million |  | 87,472 |  | (2) | $ | 1.7 | million |  |
Special |  | November 8, 2023 |  | December 15, 2023 |  | December 29, 2023 |  | $ | 0.07 |  |  | $ | 5.3 | million |  | 11,133 |  | (2) | $ | 0.2 | million |  |
Quarterly |  | January 26, 2024 |  | March 15, 2024 |  | March 29, 2024 |  | $ | 0.55 |  |  | $ | 42.8 | million |  | 96,850 |  | (2) | $ | 1.9 | million |  |
Quarterly |  | April 26, 2024 |  | June 14, 2024 |  | June 28, 2024 |  | $ | 0.55 |  |  | $ | 43.3 | million |  | 100,029 |  | (2) | $ | 1.9 | million |  |
Total for the nine months ended June 30, 2024 |  | $ | 1.72 |  |  | $ | 133.1 | million |  | 295,484 |  |  | $ | 5.7 | million |  |
__________ (1) Shares were purchased on the open market and distributed. (2) New shares were issued and distributed. (3) Totals may not sum due to rounding.
Schedule of Common Stock Issued and Sold | In connection with the "at the market" offering, the Company issued and sold 168,055 shares of common stock during the nine months ended June 30, 2025 for net proceeds of $3.0 million (net of offering costs).
|  | Number of Shares Issued |  | Gross Proceeds |  | Placement Agent Fees |  | Net Proceeds (1) |  | Average Sales Price per Share (2)
"At the market" offering |  | 168,055 |  |  | $ | 2,987 |  |  | $ | 26 |  |  | $ | 2,960 |  |  | $ | 17.77 |
(1) Net proceeds excludes offering costs of less than $0.1 million. (2) Represents the gross sales price, including supplemental payments by Oaktree, before deducting placement agent fees and estimated offering expenses. In connection with the "at the market" offering, the Company issued and sold 4,724,506 shares of common stock during the nine months ended June 30, 2024 for net proceeds of $92.5 million (net of offering costs).
|  | Number of Shares Issued |  | Gross Proceeds |  | Placement Agent Fees |  | Net Proceeds (1) |  | Average Sales Price per Share (2)
"At the market" offering |  | 4,724,506 |  |  | $ | 93,685 |  |  | $ | 937 |  |  | $ | 92,748 |  |  | $ | 19.83 |
(1) Net proceeds excludes offering costs of $0.2 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of change in net assets (equity) of investment company. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477796/946-210-45-3 + Details
Name: | us-gaap_InvestmentCompanyChangesInNetAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration